FDA approves extract for house dust mite allergic rhinitis
On March 1, the U.S. Food and Drug Administration (FDA) approved Odactra, the first allergen extract to be administered sublingually to treat house dust…
Web Exclusives
FDA approves new treatment for carcinoid syndrome
On Feb. 28, the U.S. Food and Drug Administration (FDA) approved Xermelo (telotristat ethyl) tablets in combination with somatostatin analog (SSA) therapy for the treatment…
Probiotics may help allergies
Consuming certain probiotics helps improve quality of life in seasonal allergy sufferers, according to a study in the American Journal of Clinical Nutrition. Read…
Comprehensive Reverse Shoulder System recall
On Feb. 15, the U.S. Food and Drug Administration announced that Zimmer Biomet has recalled its Biomet Comprehensive Reverse Shoulder Humeral system because of…
Incidence of pediatric multidrug-resistant enterobacteriaceae increases
According to a study in the Journal of the Infectious Diseases Society, the incidence of multidrug-resistant Gram-negative enteric Enterobacteriaceae in children increased during 2007-2015…
FDA approves new drug for Duchenne muscular dystrophy
On Feb. 9, the U.S. Food and Drug Administration (FDA) approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and…
FDA approves new drug for psoriasis
On Feb. 15, the U.S. Food and Drug Administration (FDA) approved Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Read more
Clinical tool helps identify who needs stress tests
A clinical tool can be used to reduce unnecessary stress tests in patients with stable chest pain. Read more and read the study abstract.…
AHA releases new guidelines for reversing non–vitamin K oral anticoagulants
The American Heart Association (AHA) has released a scientific statement on reversing the effects of non–vitamin K oral anticoagulants. Read more
Empowering nurses to transform health care globally: A United States-Haiti nursing partnership
Since the Magnet® Vision was published in 2008, it has inspired actions by nurses at Lehigh Valley Hospital (LVH), a Magnet-recognized academic community hospital…
What works: Code green prevents workplace violence
Over the public-announcement system at our inner-city, 500-bed hospital you hear, “Code Green, Main 5, Room 506.” That’s probably not a code you’ve heard…
New newborn screening for metabolic disorders
On Feb. 3, the U.S. Food and Drug Administration (FDA) permitted marketing of the Seeker System for the screening of four, rare Lysosomal Storage…
FDA approves extract for house dust mite allergic rhinitis
On March 1, the U.S. Food and Drug Administration (FDA) approved Odactra, the first allergen extract to be administered sublingually to treat…
FDA approves new treatment for carcinoid syndrome
On Feb. 28, the U.S. Food and Drug Administration (FDA) approved Xermelo (telotristat ethyl) tablets in combination with somatostatin analog (SSA) therapy for…
Probiotics may help allergies
Consuming certain probiotics helps improve quality of life in seasonal allergy sufferers, according to a study in the American Journal of Clinical…
Comprehensive Reverse Shoulder System recall
On Feb. 15, the U.S. Food and Drug Administration announced that Zimmer Biomet has recalled its Biomet Comprehensive Reverse Shoulder Humeral system…
Incidence of pediatric multidrug-resistant enterobacteriaceae increases
According to a study in the Journal of the Infectious Diseases Society, the incidence of multidrug-resistant Gram-negative enteric Enterobacteriaceae in children increased…
FDA approves new drug for Duchenne muscular dystrophy
On Feb. 9, the U.S. Food and Drug Administration (FDA) approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5…
FDA approves new drug for psoriasis
On Feb. 15, the U.S. Food and Drug Administration (FDA) approved Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Read more
Clinical tool helps identify who needs stress tests
A clinical tool can be used to reduce unnecessary stress tests in patients with stable chest pain. Read more and read the…
AHA releases new guidelines for reversing non–vitamin K oral anticoagulants
The American Heart Association (AHA) has released a scientific statement on reversing the effects of non–vitamin K oral anticoagulants. Read more
Empowering nurses to transform health care globally: A United States-Haiti nursing partnership
Since the Magnet® Vision was published in 2008, it has inspired actions by nurses at Lehigh Valley Hospital (LVH), a Magnet-recognized academic…
What works: Code green prevents workplace violence
Over the public-announcement system at our inner-city, 500-bed hospital you hear, “Code Green, Main 5, Room 506.” That’s probably not a code…
New newborn screening for metabolic disorders
On Feb. 3, the U.S. Food and Drug Administration (FDA) permitted marketing of the Seeker System for the screening of four, rare…
Test Your Knowledge
Cannabis TYK
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.